Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2017-07-19
2019-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Live imaging will use an algorithm to realize 'valve tracking': an automatic detection of aortic valve position and shape as fast as image acquisition time. In order to develop and validate this 'valve tracking' algorithm, CARDIAWAVE requires cardiac echographic loops of patients with aortic valve calcification, with 30 seconds or 60 seconds recording.
The objective of the present study is to develop and validate the 'valve tracking' processing algorithm of CARDIAWAVE.
ARYEL is a prospective, multicenter, non-interventional study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Clinical and Echographic Follow-up (More Than 4 Years) After TAVI.
NCT03402724
Assessment of the Prognosis of Persistent Left Bundle Branch Block (LBBB)After Transcatheter Aortic Valve Implantation (TAVI ) by an Electrophysiological and Remote Monitoring Risk-adapted Algorithm
NCT02482844
Multicenter Study Evaluating the Efficacy of an Intervention Aimed At Reducing the Length of Stay After Transfemoral Transcatheter Aortic Valve Implantation
NCT04503655
EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis
NCT03042104
Valvosoft First-In-Man Study in Severe Symptomatic Aortic Stenosis
NCT03779620
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Native valves_30 seconds loops
Patient with calcified aortic stenosis on native valve: record of a 30 second loop during routine cardiac echography.
Cardiac Echography
While routine cardiac echography is performed on patients with calcified aortic valve, a 30 second loop is recorded.
Native valves_30 and 60 seconds loops
Patient with calcified aortic stenosis on native valve: record of a 30 second loop and a 60 second loop during routine cardiac echography.
Cardiac Echography
While routine cardiac echography is performed on patients with calcified aortic valve, a 30 second loop is recorded.
Bioprosthesis_30 seconds loops
Patient with calcified aortic stenosis on bioprosthesis: record of a 30 second loop during routine cardiac echography.
Cardiac Echography
While routine cardiac echography is performed on patients with calcified aortic valve, a 30 second loop is recorded.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac Echography
While routine cardiac echography is performed on patients with calcified aortic valve, a 30 second loop is recorded.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a confirmed diagnosis of Aortic valve calcification on native valve or bioprosthesis
* Patients with planned cardiac transthoracic echography for 'Aortic valve calcification' follow-up
* Patients who have signed Informed Consent Form
* Patients affiliated to French social security or equivalent
Exclusion Criteria
* Patients with "hostile thorax": serious cutaneous irradiation injury or major thoracic deformity.
* Low echogenicity
* Patients with mild or high abundance pericardic effusion
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cardiawave SA
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Caen
Caen, , France
Hôpital Européen Georges Pompidou
Paris, , France
Hôpital Charles Nicolle
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ARYEL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.